Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Investigating the effects of inhaled corticosteroids on chronic obstructive pulmonary disease patients exposed to air pollution through single-cell RNA sequencing

FY 2022-23

Summary
With the rise in global air pollution, the prevalence of chronic obstructive pulmonary disease (COPD) is becoming an increasing health concern for nations worldwide. COPD is an inflammatory lung disease exacerbated by air pollutants including diesel exhaust (DE) and is the 3rd leading cause of death worldwide, as reported by the World Health Organization. COPD treatment involves the usage of short-acting and long-acting ?2-agonists, antimuscarinic drugs, and inhaled corticosteroids (ICS). ICS are administered as anti-inflammatory mediators as they modulate a wide array of immune and structural cell functions in the airways. However, ICS usage in COPD has been associated with an increased risk of pneumonia development. We are concerned that exposure to both an ICS and air pollution will lead to a dramatically higher pneumonia and exacerbation risk. More research is required to understand the interplay between ICS, air pollution and downstream biological pathways. An investigation of cell-specific transcriptional activity would provide insight into key genes involved in the potential adverse interactions of ICS and DE. Bulk RNA sequencing (RNA-Seq) is a commonly used method to derive average expressional differences between treatment conditions across many cell types, but is limited as the technique cannot capture data from cell subpopulations. Therefore, to determine interplay between cellular heterogeneity, an environmental exposure and ICS treatment, single-cell RNA (scRNA) sequencing will be performed to investigate cell-specific transcriptional activity and subpopulations involved in pneumonia development. This study combines a novel human exposure approach with cutting edge analysis to potentially uncover modifiable targets for improved intervention in COPD.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486034
Name
Yoon Ho Jung
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the effects of inhaled corticosteroids on chronic obstructive pulmonary disease patients exposed to air pollution through single-cell RNA sequencing
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Air Pollution; Chronic Pulmonary Obstructive Disease; Copd; Ics; Inhaled Corticosteroids; Lung Disease; Respiration; Scrna-Seq; Single Cell Rna Sequencing
Abstract
With the rise in global air pollution, the prevalence of chronic obstructive pulmonary disease (COPD) is becoming an increasing health concern for nations worldwide. COPD is an inflammatory lung disease exacerbated by air pollutants including diesel exhaust (DE) and is the 3rd leading cause of death worldwide, as reported by the World Health Organization. COPD treatment involves the usage of short-acting and long-acting ?2-agonists, antimuscarinic drugs, and inhaled corticosteroids (ICS). ICS are administered as anti-inflammatory mediators as they modulate a wide array of immune and structural cell functions in the airways. However, ICS usage in COPD has been associated with an increased risk of pneumonia development. We are concerned that exposure to both an ICS and air pollution will lead to a dramatically higher pneumonia and exacerbation risk. More research is required to understand the interplay between ICS, air pollution and downstream biological pathways. An investigation of cell-specific transcriptional activity would provide insight into key genes involved in the potential adverse interactions of ICS and DE. Bulk RNA sequencing (RNA-Seq) is a commonly used method to derive average expressional differences between treatment conditions across many cell types, but is limited as the technique cannot capture data from cell subpopulations. Therefore, to determine interplay between cellular heterogeneity, an environmental exposure and ICS treatment, single-cell RNA (scRNA) sequencing will be performed to investigate cell-specific transcriptional activity and subpopulations involved in pneumonia development. This study combines a novel human exposure approach with cutting edge analysis to potentially uncover modifiable targets for improved intervention in COPD.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yoon, Ho Jung
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~